February 8, 2025 - 06:53

Motorists traveling along Highway 7 may encounter a striking tall, orange structure, a new initiative aimed at addressing the growing concern of distracted driving. This installation is part of a $450,000 grant awarded to the Highway 7 Safety Coalition, which is dedicated to enhancing road safety in the region.
The initiative employs advanced artificial intelligence technology designed to monitor and deter distracted driving behaviors. By utilizing cutting-edge sensors and data analysis, the system aims to identify drivers who may be using their phones or engaging in other distractions while behind the wheel.
Authorities hope that the presence of this technology will serve as a powerful reminder for drivers to stay focused on the road. With distracted driving being a leading cause of accidents, this proactive approach could potentially lead to a significant reduction in incidents, promoting safer travel for all. The coalition is optimistic that this investment will pave the way for future innovations in road safety.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...